The elevation of different myocardial biomarkers on admission is associated with disease features and different outcomes in aneurysmal subarachnoid hemorrhage
Abstract Test of different myocardial biomarkers is commonly arranged in patients with aneurysmal subarachnoid hemorrhage (aSAH). We sought to figure out whether different myocardial biomarkers' elevation is related to characteristics of ruptured aneurysms and patients' clinical outcomes....
Main Authors: | Yuqi Chen, Chengzhi Cai, Jiang Fei, Song Luo, Chao You |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-10-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-20650-5 |
Similar Items
-
Biomarkers in aneurysmal subarachnoid hemorrhage: A short review
by: Sávio Batista, et al.
Published: (2023-07-01) -
Massive traumatic subarachnoid hemorrhage mimicking aneurysmal subarachnoid hemorrhage
by: Amr Rachid El Mohamad, et al.
Published: (2023-12-01) -
Identification of the key immune-related genes in aneurysmal subarachnoid hemorrhage
by: Xing Wang, et al.
Published: (2022-09-01) -
Elevated Serum CCL23 Levels at Admission Predict Delayed Cerebral Ischemia and Functional Outcome after Aneurysmal Subarachnoid Hemorrhage
by: Hongwei Lin, et al.
Published: (2022-11-01) -
Monocyte Count on Admission Is Predictive of Shunt-Dependent Hydrocephalus After Aneurysmal Subarachnoid Hemorrhage
by: Joshua A. Cuoco, et al.
Published: (2022-04-01)